| Michele Wilson, MS CCC-SLP | |
|
3148 W Central Ave, Toledo, OH 43606-2920 | |
| (419) 241-6219 | |
| (419) 241-5912 |
| Full Name | Michele Wilson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3148 W Central Ave, Toledo, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013096239 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP-7435 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michele Wilson, MS CCC-SLP 3205 Wendover Dr, Toledo, OH 43606-1863 Ph: (419) 241-6219 | Michele Wilson, MS CCC-SLP 3148 W Central Ave, Toledo, OH 43606-2920 Ph: (419) 241-6219 |
News Archive
A team of researchers from Spain and Canada recently characterized the antibody kinetics and neutralization capacity at 4 cross-sectional surveys between March and October 2020 and determined the seroprevalence in the same cohort of healthcare workers.
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell $21.0 million of shares of its Series 5 Preferred Stock in a registered offering to three institutional investors (collectively, the "Initial Purchasers"). Each share of Series 5 Preferred Stock is convertible at the option of the holder, at any time during its existence, into 2,500 shares of common stock at a conversion price of $0.40 per share of common stock, for a total of 52,500,000 shares of common stock.
With growth rates in developed markets sliding downwards, emerging markets with higher growth rates such as BRIC are expected to be the key drivers of revenue growth for multinational pharma companies. Therefore, multinational pharmaceutical corporations should have a well-planned strategy for each of the BRIC members in order to achieve global prominence.
Researchers at Cold Spring Harbor Laboratory (CSHL) have identified an enzyme that appears to be a significant regulator of breast cancer development. Called PTPN23, the enzyme is a member of a family called protein tyrosine phosphatases, or PTPs, that plays a fundamental role in switching cell signaling on and off.
People who lack essential antioxidants, and who have high levels of sunlight exposure, have a higher risk of developing advanced macular degeneration (AMD), according to a study published today in the journal Archives of Ophthalmology. AMD is the leading cause of poor vision in the UK.
› Verified 6 days ago
Beth Kanitz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3148 W Central Ave, Toledo, OH 43606 Phone: 419-241-6219 Fax: 419-241-5912 | |
Nancy Shollenberger, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3450 W Central Ave Ste 336, Toledo, OH 43606 Phone: 419-536-4247 | |
Hillary Harbaugh, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2402 Cheltenham Rd, Toledo, OH 43606 Phone: 419-671-3700 Fax: 419-671-3745 | |
Mrs. Sara Goodson, M.S. CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3450 W Central Ave, Toledo, OH 43606 Phone: 180-029-9115 | |
Theresa Herman, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3148 W Central Ave, Toledo, OH 43606 Phone: 419-241-6219 Fax: 419-241-5912 | |
Linda Bellman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3450 W Central Ave Ste 336, Toledo, OH 43606 Phone: 419-536-4247 |